The subject population comprised 2 cohorts: those with primary or secondary OAG with IOP ≥ 21 mm Hg despite topical medication or prior surgical glaucoma ... CyPass Micro-Stent is an ...

Glaucoma is a chronic eye disease characterized by damage to ... investments in next-generation implants, stents, and micro-incisional devices are expected to transform the market for glaucoma ...

Health Rounds: Adaptable implant may be improvement over heart stents October 30 ... support a change in management of the common eye disease glaucoma from eye drops, the current standard of ...

This bio-interventional technique offers a promising alternative for managing OAG, potentially becoming a valuable tool in glaucoma surgery. Iantrek, Inc. has released 1-year follow-up data from the ...

A bypass stent, canaloplasty, or trabeculotomy will be the ... Unlike in other studies, all eyes with primary open-angle glaucoma (POAG) or ocular hypertension (OHT) were pseudophakic and had ...

Glaucoma patients show slower visual response times, indicating impaired visual signal processing rather than motor or ...

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, ...

people should know that all redness of eyes is not conjunctivitis and even conditions like corneal ulcer, glaucoma can cause redness, says Dr S Soundari, regional head of clinical services at Dr ...

Anyone over the age of 60, especially Hispanics and Latinos, are at a higher risk of developing glaucoma according to the National Eye Institute – and for the Black population, the risk of ...